510(k) Report

510(k) · Cleared

Cleared

Medipoint Blood Lancets

K223480510(k) TraditionalCleared Jan 13, 202356-day reviewClass II21 CFR 878.4850

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Medipoint Holdings, LLC · QRK Single Use Only Blood Lancet Without An Integral Sharps Injury Prevention Feature

Cleared on Jan 13, 2023 as substantially equivalent to K221433 (Facet Technologies, LLC, 2022) after a 56-day review. Its family tree reaches back 1 generation to 2022.

Decided
Jan 13, 2023
Review
56 days
Class
Class II
Product code
QRK
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K221433 (2022). No later device cites it as a predicate yet.

K221433 · Facet 28G Universal Lancet · Facet Technologies, LLC · 20220
  1. Root · 1 generation backK221433 Facet 28G Universal LancetFacet Technologies, LLC · 2022
  2. This deviceK223480 Medipoint Blood LancetsMedipoint Holdings, LLC · 2023
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K221433Facet 28G Universal LancetFacet Technologies, LLC2022—
0 (this device)K223480Medipoint Blood LancetsMedipoint Holdings, LLC2023—
FIG. 1 — Lineage of K223480, 2022–2023Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in QRK? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new QRK device

  1. #1 K221507 Disposable Blood Lancetscore 16.5 · 3 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K221433Facet 28G Universal Lancet
Summary page 4
…ry Predicate: Medipoint Blood Lancets (510(k)-Exempt prior to reclassification) Secondary Predicate: Facet Technologies LLC Facet 28G Universal Lancet (K221433) 1…
Facet Technologies, LLC2022—
*—Medipoint Blood Lancets
Named without a submission number
—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.

How does its category compare?

All QRK devices

QRK Single Use Only Blood Lancet Without An Integral Sharps Injury Prevention Feature: FDA decisions, review times, recalls and adverse event reports over 20 years. 2023, this device’s year, is highlighted.

FDA decisions per year · QRK

2in 2025

2022: 32023: 72024: 32025: 22026 (partial year): 2
2007high 7 (2023) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · QRK

55in 2024

2022: 100 days median2023: 89 days median2024: 55 days median
2007high 100 (2022) · low 55 (2024)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · QRK

No recall names QRK since 2007.

Adverse event reports per year · QRK

9in 2025

2022: 22023: 122024: 102025: 9
2007high 12 (2023) · low 0 (2007)2025

MAUDE reports naming product code QRK, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20180—00
20190—00
20200—00
20210—00
2022310002
2023789012
2024355010
20252—09
20262—0—

What is it indicated for?

Medipoint Blood Lancets are indicated to obtain a capillary blood sample from the fingertip for testing utilizing small amounts of blood.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K223480: Medipoint Blood Lancets.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K223480

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026